162854-89-9Relevant articles and documents
BORONATE MEDICAMENTS FOR PREVENTING THROMBOSIS DURING SURGERY
-
Page/Page column 64, (2010/02/14)
The use for the manufacture of a medicament for preventing unwanted coagulation during surgery, and particularly a Coronary Artery Bypass Graft (CABG) procedure, of boronic acids of formula (I), and salts, prodrugs and prodrug salts thereof; wherein Y com
BORONIC ACID THROMBIN INHIBITORS
-
Page/Page column 65, (2010/02/14)
A thrombin inhibitor selected from boronic acids of formula (I), and salts, prodrugs and prodrug salts thereof: wherein X is H (to form NH2) or an amino-protecting group; aal is an amino acid residue having a side chain selected from formula (A) and (B)-(CO)a-(CH2)b-Dc-(CH2)d-E (A), -(CO)a-(CH2)b-Dc-Ce(E1)(E2)(E3) wherein E1, E2 and E3 ore 5-6 membered saturated or unsaturated hydrocarbyl rings, or one of E1 , E2 and E3 is hydrogen and the other two are a said hydrocarbyl ring, E, E1, E2 and E3 optionally being halogenated when saturated and mandatorily being halogenated when unsaturated, a particular halogen being fluorine; aa2 is a residue of an amino acid which binds to the thrombin S2 subsite; and R9 is a straight chain alkyl group interrupted by one or more ether linkages or R9 is -(CH2)m W and W is -OH or halogen.